SAN FRANCISCO – IBM Watson Health was a star at this year's J.P. Morgan Healthcare conference, announcing two deals with high profile players. The latest was with the U.S. FDA to work together to define a way for to exchange health data across a variety of technology platforms with an initial focus on oncology data.